Cisplatin-resistant cells in malignant pleural mesothelioma cell lines show ALDHhighCD44+ phenotype and sphere-forming capacity
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Cisplatin-resistant cells in malignant pleural mesothelioma cell lines show ALDHhighCD44+ phenotype and sphere-forming capacity
Authors
Keywords
Cancer stem cells, Malignant pleural mesothelioma, Chemoresistance, ALDH, CD44
Journal
BMC CANCER
Volume 14, Issue 1, Pages -
Publisher
Springer Nature
Online
2014-05-01
DOI
10.1186/1471-2407-14-304
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Lung cancer tumorigenicity and drug resistance are maintained through ALDHhi CD44hi tumor initiating cells
- (2015) Jing Liu et al. Oncotarget
- ALDH1-Bright Epithelial Ovarian Cancer Cells Are Associated with CD44 Expression, Drug Resistance, and Poor Clinical Outcome
- (2012) Yu-Chi Wang et al. AMERICAN JOURNAL OF PATHOLOGY
- Cancer Stem Cells: Impact, Heterogeneity, and Uncertainty
- (2012) Jeffrey A. Magee et al. CANCER CELL
- ALDH-positive lung cancer stem cells confer resistance to epidermal growth factor receptor tyrosine kinase inhibitors
- (2012) Cheng-Po Huang et al. CANCER LETTERS
- Inhibition of aldehyde dehydrogenase (ALDH) activity reduces chemotherapy and radiation resistance of stem-like ALDHhiCD44+ human breast cancer cells
- (2011) Alysha K. Croker et al. BREAST CANCER RESEARCH AND TREATMENT
- Aldehyde dehydrogenase: Its role as a cancer stem cell marker comes down to the specific isoform
- (2011) Paola Marcato et al. CELL CYCLE
- The enzymatic activity of human aldehyde dehydrogenases 1A2 and 2 (ALDH1A2 and ALDH2) is detected by Aldefluor, inhibited by diethylaminobenzaldehyde and has significant effects on cell proliferation and drug resistance
- (2011) Jan S. Moreb et al. CHEMICO-BIOLOGICAL INTERACTIONS
- Hyaluronan-CD44 interactions as potential targets for cancer therapy
- (2011) Suniti Misra et al. FEBS Journal
- Aldehyde dehydrogenases and cell proliferation
- (2011) G. Muzio et al. FREE RADICAL BIOLOGY AND MEDICINE
- Aldehyde dehydrogenase-1 is a specific marker for stem cells in human lung adenocarcinoma
- (2011) Dong Liang et al. MEDICAL ONCOLOGY
- SASP mediates chemoresistance and tumor-initiating-activity of mesothelioma cells
- (2011) C Canino et al. ONCOGENE
- Evidence for self-renewing lung cancer stem cells and their implications in tumor initiation, progression, and targeted therapy
- (2010) James P. Sullivan et al. CANCER AND METASTASIS REVIEWS
- Aldehyde Dehydrogenase Activity Selects for Lung Adenocarcinoma Stem Cells Dependent on Notch Signaling
- (2010) J. P. Sullivan et al. CANCER RESEARCH
- Finding cancer stem cells: are aldehyde dehydrogenases fit for purpose?
- (2010) Malcolm R Alison et al. JOURNAL OF PATHOLOGY
- Oxymatrine diminishes the side population and inhibits the expression of β-catenin in MCF-7 breast cancer cells
- (2010) Ying Zhang et al. MEDICAL ONCOLOGY
- Cucurbitacin I Suppressed Stem-Like Property and Enhanced Radiation-Induced Apoptosis in Head and Neck Squamous Carcinoma-Derived CD44+ALDH1+ Cells
- (2010) Y.-W. Chen et al. MOLECULAR CANCER THERAPEUTICS
- Aldehyde Dehydrogenase (ALDH) Activity Does Not Select for Cells with Enhanced Aggressive Properties in Malignant Melanoma
- (2010) Lina Prasmickaite et al. PLoS One
- Non-Small Cell Lung Cancer Cells Expressing CD44 Are Enriched for Stem Cell-Like Properties
- (2010) Elaine Lai-Han Leung et al. PLoS One
- High ALDH Activity Identifies Chemotherapy-Resistant Ewing's Sarcoma Stem Cells That Retain Sensitivity to EWS-FLI1 Inhibition
- (2010) Ola Awad et al. PLoS One
- The Role of Human Aldehyde Dehydrogenase in Normal and Cancer Stem Cells
- (2010) Irene Ma et al. Stem Cell Reviews and Reports
- Aldehyde Dehydrogenase Activity of Breast Cancer Stem Cells Is Primarily Due To Isoform ALDH1A3 and Its Expression Is Predictive of Metastasis
- (2010) Paola Marcato et al. STEM CELLS
- Hyaluronan-CD44 Interactions in Cancer: Paradoxes and Possibilities
- (2009) B. P. Toole CLINICAL CANCER RESEARCH
- Valproate, in Combination with Pemetrexed and Cisplatin, Provides Additional Efficacy to the Treatment of Malignant Mesothelioma
- (2009) F. Vandermeers et al. CLINICAL CANCER RESEARCH
- Aldehyde Dehydrogenase 1 Is a Tumor Stem Cell-Associated Marker in Lung Cancer
- (2009) F. Jiang et al. MOLECULAR CANCER RESEARCH
- Systemic Treatments for Mesothelioma: Standard and Novel
- (2008) Hedy Lee Kindler CURRENT TREATMENT OPTIONS IN ONCOLOGY
- ALDH isozymes downregulation affects cell growth, cell motility and gene expression in lung cancer cells
- (2008) Jan S Moreb et al. Molecular Cancer
- Colorectal Cancer Stem Cells Are Enriched in Xenogeneic Tumors Following Chemotherapy
- (2008) Scott J. Dylla et al. PLoS One
- Drug-Selected Human Lung Cancer Stem Cells: Cytokine Network, Tumorigenic and Metastatic Properties
- (2008) Vera Levina et al. PLoS One
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started